Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Axsome Therapeutics, Inc. - Common Stock (NQ:AXSM)

217.99 -16.65 (-7.10%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jul 31, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Axsome Therapeutics, Inc. - Common Stock

< Previous 1 2
...
19 20 21 22 23 24 25 26 Next >
News headline image
INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Axsome Therapeutics, Inc. (AXSM) on Behalf of Investors
From Law Offices of Howard G. Smith
Via Business Wire
News headline image
The Law Offices of Frank R. Cruz Announces Investigation of Axsome Therapeutics, Inc. (AXSM) on Behalf of Investors
From The Law Offices of Frank R. Cruz
Via Business Wire
News headline image
SHAREHOLDER ACTION REMINDER: The Schall Law Firm Encourages Investors in Axsome Therapeutics, Inc. with Losses of $500,000 to Contact the Firm
From The Schall Law Firm
Via Business Wire
News headline image
Where Axsome Therapeutics Stands With Analysts ↗
Analysts have provided the following ratings for Axsome Therapeutics (NASDAQ:AXSM) within the last quarter: 
Via Benzinga
News headline image
As Expected, FDA Rejects Axsome Therapeutics' Migraine Candidate ↗
 
Via Benzinga
News headline image
Recap: Axsome Therapeutics Q1 Earnings ↗
Axsome Therapeutics (NASDAQ:AXSM) reported its Q1 earnings results on Monday, May 2, 2022 at 07:00 AM. Here's what investors need to know about the announcement. 
Via Benzinga
News headline image
INVESTOR ALERT: Axsome Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - AXSM
From Robbins Geller Rudman & Dowd LLP
Via Business Wire
News headline image
SHAREHOLDER ACTION ALERT: The Schall Law Firm Encourages Investors in Axsome Therapeutics, Inc. With Losses of $500,000 to Contact the Firm
From The Schall Law Firm
Via Business Wire
News headline image
EQUITY ALERT: ROSEN, A LEADING LAW FIRM, Encourages Axsome Therapeutics, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action – AXSM
From The Rosen Law Firm, P.A.
Via Business Wire
News headline image
Axsome Poised To Receive FDA Rejection For Its Migraine Candidate, Shares Fall ↗
 
Via Benzinga
News headline image
Jazz Pharmaceuticals Completes U.S. Divestiture Of Sunosi To Axsome Therapeutics, What's Next? ↗
Jazz Pharmaceuticals plc (NASDAQ: JAZZ) has completed the divestiture of Sunosi (solriamfetol) in the U.S. 
Via Benzinga
News headline image
FDA Issues Complete Response Letter (CRL) to Axsome Therapeutics for AXS-07 In Acute Migraine ↗
The U.S. Food and Drug Administration (FDA) issued a Complete Response Letter (CRL) to Axsome Therapeutics, Inc. (NASDAQ: AXSM) regarding its New Drug Application (NDA) for AXS-07 for the acute... 
Via Benzinga
News headline image
5 Trending Tickers On Benzinga For May 2, 2022: Activision, SoundHound And More ↗
Benzinga’s “Daily Brief On Trending Tickers” highlights top-searched tickers from around the web and uses the Benzinga Pro platform to highlight recent news... 
Via Benzinga
News headline image
A Preview Of Axsome Therapeutics's Earnings ↗
Axsome Therapeutics (NASDAQ:AXSM) is set to give its latest quarterly earnings report on Monday, 2022-05-02. Here's what investors need to know before the announcement. Analysts estimate that Axsome... 
Via Benzinga
News headline image
AXSOME ALERT: Bragar Eagel & Squire, P.C. is Investigating Axsome Therapeutics, Inc. on Behalf of Axsome Stockholders and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire, P.C.
Via Business Wire
News headline image
92 Biggest Movers From Friday ↗
Gainers Sidus Space, Inc. (NASDAQ: SIDU) jumped 51.8% to settle at $2.99 on Friday after the company announced a a memorandum of understanding with Dhruva Space to expand its partnership to further the... 
Via Benzinga
News headline image
Earnings Scheduled For May 2, 2022 ↗
Companies Reporting Before The Bell • New Gold (AMEX:NGD) is estimated to report quarterly earnings at $0.03 per share on revenue of $212.42 million. 
Via Benzinga
News headline image
Axsome Therapeutics Earnings Conference Call Is Coming Up, Here's What You Need To Know ↗
Axsome Therapeutics (NASDAQ:AXSM) will host a conference call at 08:00 AM ET on May 2, 2022, to discuss Q1 2022 earnings results. 
Via Benzinga
News headline image
60 Biggest Movers From Yesterday ↗
Gainers Nkarta, Inc. (NASDAQ: NKTX) shares climbed 140.9% to close at $18.72 on Monday after the company announced Phase 1 data from independent dose finding studies of its two... 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Monday's Intraday Session ↗
 
Via Benzinga
News headline image
34 Stocks Moving In Monday's Mid-Day Session ↗
Gainers Nkarta, Inc. (NASDAQ: NKTX) shares jumped 108.6% to $16.21 after the company announced Phase 1 data from independent dose finding studies of its two lead chimeric antigen... 
Via Benzinga
News headline image
Why Is Axsome Therapeutics (AXSM) Stock Down Today? ↗
Axsome Therapeutics (AXSM) stock is falling hard on Monday following a report about an upcoming decision from the FDA this week. 
Via InvestorPlace
News headline image
Mid-Morning Market Update: Markets Open Lower; Dow Tumbles Over 300 Points ↗
U.S. stocks opened lower this morning, with the Dow Jones dropping more than 300 points on Monday. 
Via Benzinga
News headline image
Axsome Therapeutics' Good Fortune Reverses As Its Migraine Drug Hits A Hurdle ↗
Last week, Axsome stock soared on its depression drug. This week is a different story. 
Via Investor's Business Daily
News headline image
Why Axsome Therapeutics Stock Is Falling Today ↗
Axsome Therapeutics Inc (NASDAQ: AXSM) shares are trading higher Monday after the company reported it was informed by the U.S. Food and Drug Administration (FDA) that... 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Monday's Pre-Market Session ↗
 
Via Benzinga
News headline image
The Week Ahead In Biotech (April 24-April 30): Bristol-Myers Squibb, Supernus, Hutchmed, Axsome, Coherus FDA Decisions, Big Pharma Earnings, IPOs And More ↗
Biotech stocks extended their loses in the week ending April 22. The sector took cues from the broader market, which reacted to the lackluster start of the first-quarter reporting season and lingering... 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Tuesday's Intraday Session ↗
Gainers Checkmate Pharmaceuticals (NASDAQ:CMPI) stock increased by 331.9% to $10.41 during Tuesday's regular session. Trading volume for Checkmate Pharmaceuticals'... 
Via Benzinga
News headline image
54 Biggest Movers From Yesterday ↗
Gainers Checkmate Pharmaceuticals, Inc. (NASDAQ: CMPI) shares jumped 325.9% to close at $10.35 on Tuesday after Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) announced a deal to... 
Via Benzinga
News headline image
Dow Up Over 400 Points as Wall Street Pores Over Earnings ↗
Stocks are pointed higher this afternoon, as Wall Street pores over the latest batch of quarterly reports amid one of the busiest weeks of earnings season. 
Via Talk Markets
< Previous 1 2
...
19 20 21 22 23 24 25 26 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.